Potential anti-TB investigational compounds and drugs with repurposing potential in TB therapy: a conspectus

AA Adeniji, KE Knoll, DT Loots - Applied microbiology and biotechnology, 2020 - Springer
The latest WHO report estimates about 1.6 million global deaths annually from TB, which is
further exacerbated by drug-resistant (DR) TB and comorbidities with diabetes and HIV …
被引用次数：34 相关文章

Potential anti-TB investigational compounds and drugs with repurposing potential in TB therapy: a conspectus

AA Adeniji, KE Knoll, L Du Toit - Applied Microbiology and …, 2020 - search.proquest.com
The latest WHO report estimates about 1.6 million global deaths annually from TB, which is
further exacerbated by drug-resistant (DR) TB and comorbidities with diabetes and HIV …

Potential anti-TB investigational compounds and drugs with repurposing potential in TB therapy: a conspectus.

AA Adeniji, KE Knoll, DT Loots - Applied Microbiology and …, 2020 - europepmc.org
The latest WHO report estimates about 1.6 million global deaths annually from TB, which is
further exacerbated by drug-resistant (DR) TB and comorbidities with diabetes and HIV …

Potential anti-TB investigational compounds and drugs with repurposing potential in TB therapy: a conspectus.

AA Adeniji, KE Knoll, DT Loots - Applied Microbiology & …, 2020 - search.ebscohost.com
The latest WHO report estimates about 1.6 million global deaths annually from TB, which is
further exacerbated by drug-resistant (DR) TB and comorbidities with diabetes and HIV …

Potential anti-TB investigational compounds and drugs with repurposing potential in TB therapy: a conspectus

AA Adeniji, KE Knoll, DT Loots - 2020 - repository.nwu.ac.za
The latest WHO report estimates about 1.6 million global deaths annually from TB, which is
further exacerbated by drug-resistant (DR) TB and comorbidities with diabetes and HIV …

Potential anti-TB investigational compounds and drugs with repurposing potential in TB therapy: a conspectus

AA Adeniji, KE Knoll - Applied microbiology and …, 2020 - pubmed.ncbi.nlm.nih.gov
The latest WHO report estimates about 1.6 million global deaths annually from TB, which is
further exacerbated by drug-resistant (DR) TB and comorbidities with diabetes and HIV …

Potential anti-TB investigational compounds and drugs with repurposing potential in TB therapy: a conspectus

AA Adeniji, KE Knoll, DT Loots - Applied Microbiology and …, 2020 - hero.epa.gov
The latest WHO report estimates about 1.6 million global deaths annually from TB, which is
further exacerbated by drug-resistant (DR) TB and comorbidities with diabetes and HIV …

[引用][C] Potential anti-TB investigational compounds and drugs with repurposing potential in TB therapy: a conspectus

AA Adeniji, KE Knoll - 2020